Navigator‐3, a modulator of cell migration, may act as a suppressor of breast cancer progression

Author:

Cohen‐Dvashi Hadas1,Ben‐Chetrit Nir1,Russell Roslin2,Carvalho Silvia1,Lauriola Mattia1,Nisani Sophia1,Mancini Maicol1,Nataraj Nishanth1,Kedmi Merav1,Roth Lee1,Köstler Wolfgang1,Zeisel Amit3,Yitzhaky Assif3,Zylberg Jacques4,Tarcic Gabi1,Eilam Raya1,Wigelman Yoav1,Will Rainer5,Lavi Sara1,Porat Ziv6,Wiemann Stefan5,Ricardo Sara7,Schmitt Fernando7,Caldas Carlos2,Yarden Yosef1

Affiliation:

1. Department of Biological Regulation Weizmann Institute of Science Rehovot Israel

2. Cancer Research UK Cambridge Research Institute Li Ka Shing Centre Cambridge UK

3. Physics of Complex Systems Weizmann Institute of Science Rehovot Israel

4. Chemical Physics Weizmann Institute of Science Rehovot Israel

5. Division of Molecular Genome Analysis German Cancer Research Centre (DKFZ) Heidelberg Germany

6. Biological Services Weizmann Institute of Science Rehovot Israel

7. IPATIMUP ‐ Institute of Molecular Pathology and Immunology Medical Faculty of the University of Porto Porto Portugal

Publisher

EMBO

Subject

Molecular Medicine

Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3